Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China

S Jiang, Y Wang, L Si, X Zang, YY Gu, Y Jiang… - BMJ Global …, 2022 - gh.bmj.com
Introduction Productivity loss may contribute to a large proportion of costs of health
conditions in an economic evaluation from a societal perspective, but there is currently a …

Patient preferences in targeted pharmacotherapy for cancers: a systematic review of discrete choice experiments

S Jiang, R Ren, Y Gu, V Jeet, P Liu, S Li - Pharmacoeconomics, 2023 - Springer
Background Targeted pharmacotherapy has been increasingly applied in cancer treatment
due to its breakthroughs. However, the unmet needs of cancer patients are still significant …

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life

D Cai, S Shi, S Jiang, L Si, J Wu, Y Jiang - The European Journal of Health …, 2022 - Springer
Cost-effective threshold (CET) is essential for health technology assessment and decision-
making based on health economic evaluations. Recently, it has been argued that the …

Genome sequencing for newborn screening—An effective approach for tackling rare diseases

S Jiang, H Wang, Y Gu - JAMA Network Open, 2023 - jamanetwork.com
Newborn screening is a crucial global public health initiative, with a primary aim to identify
congenital disorders that could lead to significant morbidity and mortality if left untreated …

Breast cancer screening should embrace precision medicine: evidence by reviewing economic evaluations in China

J Jiang, S Jiang, A Ahumada-Canale, Z Chen, L Si… - Advances in …, 2023 - Springer
The cost-effectiveness of conventional population-based breast cancer screening strategies
(eg mammography) has been found controversial, while evidence shows that genetic testing …

Prophylactic interventions for hereditary breast and ovarian cancer risks and mortality in BRCA1/2 carriers

T Liu, J Yu, Y Gao, X Ma, S Jiang, Y Gu, W Ming - Cancers, 2023 - mdpi.com
Simple Summary Prophylactic interventions are critical for BRCA1/2 mutation carriers to
reduce the risks of hereditary breast and ovarian cancer (HBOC). This systematic review and …

Reframing optimal control problems for infectious disease management in low-income countries

M Igoe, R Casagrandi, M Gatto, CM Hoover… - Bulletin of mathematical …, 2023 - Springer
Optimal control theory can be a useful tool to identify the best strategies for the management
of infectious diseases. In most of the applications to disease control with ordinary differential …

Incorporating future unrelated medical costs in cost-effectiveness analysis in China

S Jiang, Y Wang, J Zhou, Y Jiang, GG Liu, J Wu - BMJ Global Health, 2021 - gh.bmj.com
The occurrence of future unrelated medical costs is a direct consequence of life-prolonging
interventions, but most pharmacoeconomic guidelines recommend the exclusion of these …

Pharmacoeconomics of obesity in China: a scoping review

Z Chen, S Jiang, Y Wang, MM Khan… - Expert Review of …, 2021 - Taylor & Francis
Background: With the growing rate of obesity and associated chronic conditions in China,
there is a need to assess the health and economic burdens of obesity and examine the …

Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia

M Wang, S Jiang, B Li, B Parkinson, J Lu, K Tan… - Global Health Research …, 2024 - Springer
Background Familial hypercholesterolemia (FH) is a prevalent genetic disorder with global
implications for severe cardiovascular diseases. Motivated by the growing recognition of the …